C07J 21/00
Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero
Official title: Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
C07J21/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero) appears on 482 US grants and 311 published applications in this corpus.
Search patents in C07J- Granted patents
- 482
- Published applications
- 311
- Assignees
- 192
- Inventors
- 914
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 15 | 0 |
| 1978 | 15 | 0 |
| 1979 | 14 | 0 |
| 1980 | 13 | 0 |
| 1981 | 16 | 0 |
| 1982 | 9 | 0 |
| 1983 | 6 | 0 |
| 1984 | 13 | 0 |
| 1985 | 18 | 0 |
| 1986 | 14 | 0 |
| 1987 | 8 | 0 |
| 1988 | 4 | 0 |
| 1989 | 8 | 0 |
| 1990 | 14 | 0 |
| 1991 | 8 | 0 |
| 1992 | 10 | 0 |
| 1993 | 14 | 0 |
| 1994 | 11 | 0 |
| 1995 | 14 | 0 |
| 1996 | 10 | 0 |
| 1997 | 14 | 0 |
| 1998 | 16 | 0 |
| 1999 | 6 | 0 |
| 2000 | 12 | 0 |
| 2001 | 8 | 0 |
| 2002 | 2 | 7 |
| 2003 | 5 | 10 |
| 2004 | 4 | 20 |
| 2005 | 7 | 11 |
| 2006 | 9 | 9 |
| 2007 | 5 | 11 |
| 2008 | 5 | 11 |
| 2009 | 3 | 7 |
| 2010 | 6 | 12 |
| 2011 | 4 | 5 |
| 2012 | 7 | 6 |
| 2013 | 6 | 13 |
| 2014 | 3 | 11 |
| 2015 | 10 | 11 |
| 2016 | 11 | 19 |
| 2017 | 12 | 15 |
| 2018 | 10 | 15 |
| 2019 | 14 | 16 |
| 2020 | 9 | 20 |
| 2021 | 12 | 23 |
| 2022 | 11 | 10 |
| 2023 | 6 | 13 |
| 2024 | 5 | 15 |
| 2025 | 9 | 15 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Neuroactive steroids and methods of use thereof5 May 2026US 12,617,814 B2Sage Therapeutics, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure23 Dec 2025US 12,503,484 B2Seismic Pharmaceuticals
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- Method for synthesizing ursodeoxycholic acid using BA as raw material14 Oct 2025US 12,441,759 B2Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
- Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure7 May 2026US 2026/0125415 A1Seismic Pharmaceuticals Operations LLC
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116911 A1Sage Therapeutics, Inc.
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116912 A1Sage Therapeutics, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- 19-Oxygenated-5.alpha.-androstanes for the enhancement of libido91US 4,071,625 ARichardson-Merrell Inc. · 1978
- 17-Hydroxy-steroids72US 4,898,694 A1990
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series70US 5,232,917 AUniversity of Southern California · 1993